Vivani Medical, Inc.
VANI
$0.99
-$0.02-1.98%
| Weiss Ratings | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.36 | |||
| Price History | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.00% | |||
| 30-Day Total Return | -16.10% | |||
| 60-Day Total Return | -22.66% | |||
| 90-Day Total Return | -23.26% | |||
| Year to Date Total Return | -17.50% | |||
| 1-Year Total Return | -51.35% | |||
| 2-Year Total Return | 7.66% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -54.50% | |||
| 52-Week Low % Change | 1.00% | |||
| Price | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.22 | |||
| 52-Week Low Price | $1.00 | |||
| 52-Week Low Price (Date) | Apr 01, 2025 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 59.83M | |||
| Enterprise Value | 60.79M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.44 | |||
| Earnings Per Share Growth | -22.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 3.04 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.99 | |||
| Enterprise Value/EBITDA (TTM) | -2.53 | |||
| Enterprise Value/EBIT | -2.49 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 55.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 506 8462 | |||
| Address | 1350 South Loop Road Alameda, CA 94502 | |||
| Website | www.vivani.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.74% | |||
| Return on Equity | -- | |||
| Income Statement | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -24.03M | |||
| EBIT (TTM) | -24.43M | |||
| Net Income (TTM) | -23.46M | |||
| Net Income Avl. to Common (TTM) | -23.46M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 10.93% | |||
| EPS Diluted (TTM) | -0.44 | |||
| EPS Diluted Growth (Q YOY) | 18.07% | |||
| Balance Sheet | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.65M | |||
| Cash Per Share (Q) | $0.36 | |||
| Total Current Assets (Q) | 21.40M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 18.33M | |||
| Current Ratio (Q) | 3.413 | |||
| Book Value Per Share (Q) | $0.33 | |||
| Total Assets (Q) | 42.90M | |||
| Total Current Liabilities (Q) | 6.27M | |||
| Total Debt (Q) | 19.68M | |||
| Total Liabilities (Q) | 24.56M | |||
| Total Common Equity (Q) | 18.33M | |||
| Cash Flow | VANI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.00M | |||
| Cash from Financing (TTM) | 14.25M | |||
| Net Change in Cash (TTM) | -5.20M | |||
| Levered Free Cash Flow (TTM) | -11.26M | |||
| Cash from Operations (TTM) | -18.46M | |||
